IP Proposals Not Likely to Satisfy
The California stem cell agency is beginning to leave sharper clues concerning its direction on intellectual property policies – the rules that will determine what kind of return the state receives on its $6 billion research investment.
At its meeting Tuesday in Duarte, the agency is scheduled to consider basic, interim IP regulations for its training gr…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.